IceCure Medical Ltd. ICCM

1.73 0.00 0.00% as of 25 Sep
Market cap
$6.5M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
12.98 19.09 455.31 311.69 697.06 198.99 0.00 0.00 0.00 0.00
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(3.68) (6.14) (160.75) (210.79) (485.71) (301.05) (310.05) 0.00 0.00 0.00
P/B ratio
3.88 7.44 130.53 61.97 106.19 196.69 187.39 0.00 0.00 0.00
Price to Tangible BV
3.88 7.44 130.53 61.97 106.19 196.69 187.39 0.00 0.00 0.00
EV/Sales
9.75 16.38 452.28 307.06 691.02 198.41 0.00 0.00 0.00 0.00
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
(1.06) (1.88) (66.20) (57.61) (225.15) (131.14) 0.00 0.00 0.00 0.00
EV/FCF
(1.06) (1.84) (62.25) (54.65) (216.01) (131.14) 0.00 0.00 0.00 0.00
Quick Ratio
1.91 1.41 2.88 5.54 6.49 0.97 1.63 3.81 0.97 5.17
Current Ratio
2.61 1.95 3.66 6.49 7.54 2.58 1.93 4.42 1.18 5.79
Net Debt/EBITDA
0.60 0.48 0.70 1.43 2.60 0.83 1.20 1.28 0.20 0.92
Debt/Assets
0.09% 1.28% 2.29% 1.42% 2.12% 1.15% 1.44% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.02 0.03 0.02 0.03 0.02 0.03 0.00 (3.64) 0.00
Asset Turnover
0.26 0.23 0.14 0.10 0.19 0.44 0.26 0.41 0.42 0.24
Operating CF/Net income
0.97 0.82 0.86 0.84 1.27 0.99 0.44 0.87 0.91 0.96
Capex/Depreciation
(0.12) (0.21) (1.49) (3.59) (4.20) (3.54) (3.22) 0.00 0.00 0.00
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(188.78%) (160.70%) (77.97%) (64.83%) (60.69%) (83.45%) (136.41%) (227.23%) (311.54%) (354.30%)
ROA
(113.79%) (105.69%) (62.89%) (54.36%) (46.54%) (42.59%) (72.51%) (134.53%) (173.60%) (124.73%)
ROIC
(5,648.95%) 0.00% (659.11%) (551.50%) (300.57%) (114.34%) 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(171.61%) (235.95%) (123.90%) (67.51%) (36.63%) (60.34%) (131.57%) (87.05%) (863.13%) (119.75%)
Average Days of Receivables
35.75 24.51 11.64 9.23 40.22 8.87 3.81 85.26 33.06 38.38
Research and Development Expense of Revenue
219.98% 215.62% 256.21% 295.72% 142.03% 98.47% 184.45% 191.53% 215.73% 264.34%
Selling, General and Administrative Expense of Revenue
263.01% 305.41% 266.43% 293.71% 146.01% 71.79% 141.79% 155.41% 194.24% 264.88%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
40.63% 26.41% 40.57% 60.45% 7.64% 5.92% 22.86% 0.00% 0.00% 0.00%
Graham Net Nets
0.22 0.10 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(23.90%) (15.07%) (7.99%) (9.79%) (5.29%) (1.04%) (1.99%) (1.99%) (1.99%) (1.99%)
Free Cash Flow Yield
(70.71%) (46.66%) (1.60%) (1.80%) (0.46%) (0.76%) 0.00% 0.00% 0.00% 0.00%
Revenue per Share
1.60 1.94 2.12 2.50 4.35 6.78 3.59 0.09 0.11 0.12
Operating CF per Share
(6.88) (7.42) (8.26) (11.59) (13.26) (6.47) (4.38) (0.26) (0.41) (0.59)
Capex per Share
(0.02) (0.04) (0.32) (0.72) (0.56) (0.39) (0.23) 0.00 0.00 0.00
Free Cash Flow per Share
(6.90) (7.46) (8.57) (12.32) (13.82) (6.86) (4.61) (0.26) (0.41) (0.59)
Cash per Share
4.20 4.46 7.28 19.43 26.95 6.14 12.76 0.36 0.23 0.53
Shareholders Equity per Share
4.28 4.07 8.00 20.62 28.36 9.90 7.26 0.29 (0.04) 0.40
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
4.28 4.07 8.00 20.62 28.36 9.90 7.26 0.29 (0.04) 0.40
Free Cash Flow
(14.61) (12.63) (13.03) (15.18) (13.14) (3.91) (2.09) (3.08) (2.63) (3.14)
Working Capital
7.78 5.24 10.31 23.79 26.30 5.88 3.31 4.00 0.29 2.67
Capital Expenditures
(0.04) (0.07) (0.48) (0.89) (0.53) (0.22) (0.10) (0.06) (0.01) (0.02)
Net Current Asset Value
7.77 5.08 9.94 23.36 25.00 5.00 2.88 4.00 0.29 2.67
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.01 0.02 0.15 0.29 0.13 0.06 0.06 0.00 0.00 0.00
Net Profit Margin
(445.61%) (465.45%) (453.76%) (550.34%) (239.13%) (96.43%) (279.72%) (329.70%) (417.15%) (522.82%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.30 0.27 0.21 0.18 0.18 0.21 0.22 0.42 0.76 0.87
Cash ROIC
(86.67%) (94.46%) (59.59%) (31.42%) (25.00%) (43.13%) (23.26%) (41.50%) (124.90%) (64.91%)
Accounts Receivable Turnover
12.24 20.31 35.68 11.55 15.05 69.69 12.12 6.86 10.75 9.76
Accounts Payable Turnover
2.06 2.12 3.17 2.06 2.55 2.65 2.50 2.15 3.81 3.02
Inventory Turnover
0.93 0.86 0.75 0.68 1.29 1.63 1.65 1.36 1.70 1.35
Average Days of Payables
146.31 244.39 94.99 158.91 165.50 165.33 141.63 254.68 105.42 108.75
Days of Inventory on Hand
445.02 394.36 430.47 635.86 367.25 272.72 224.36 367.24 207.66 278.45
Average Receivables
0.28 0.16 0.09 0.27 0.28 0.06 0.13 0.16 0.06 0.06
Average Payables
1.05 0.87 0.61 0.80 0.76 0.54 0.44 0.30 0.14 0.14
Average Inventory
2.31 2.13 2.57 2.41 1.51 0.87 0.67 0.48 0.31 0.31
Average Assets
13.23 14.49 23.30 31.23 21.26 8.76 6.28 2.64 1.66 2.63
Average Common Equity
7.98 9.53 18.79 26.19 16.30 4.47 3.34 1.56 0.92 0.92

Fold the line items

Columns are period end dates